Skip to main content
Clinical Trials/NL-OMON41871
NL-OMON41871
Withdrawn
Not Applicable

Catheter ablation versus video assisted thoracoscopic surgery for the treatment of (longstanding) persistent atrial fibrillation - The CAVIAR-trial

niversitair Medisch Centrum Utrecht0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial fibrillation
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
60
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \- Patients age is \* 18 years
  • \- Patients with persistent or longstanding persistent atrial fibrillation.
  • \- Patients undergoing a first time invasive treatment procedure for persistent atrial fibrillation
  • \- AF must be recorded at least once by ECG, holter, telemetry, loop recorder or internal device.
  • \- Patients must give informed consent to participate

Exclusion Criteria

  • \- Patients suffering from paroxysmal atrial fibrillation
  • \- Patients with any exclusion criteria or contra\-indications for electrophysiologic study and ablation in the left atrium, such as pregnancy or presence of a left atrial thrombus
  • \- Patients with any contra\-indications for VATS such as pleural adhesions, elevated hemidiaphragm or prior lung/cardiac surgery
  • \- Active infection or sepsis
  • \- Body mass index\> 40
  • \- mitral or aortic valve regurgitation above grade 2
  • \- moderate to severe mitral or aortic stenosis

Outcomes

Primary Outcomes

Not specified

Similar Trials